Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo

X Xuexiang Han Y Ying Xu A Adele S. Ricciardi (Department of Bioengineering) J Junchao Xu (Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States) Y Yan Xiang (Department of Biomedical Engineering, Duke University) R Rohan Palanki V Vivek Chowdhary (Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania) L Lulu Xue (Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States) N Ningqiang Gong (Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States) M Mohamad-Gabriel Alameh W William H. Peranteau (Division of Pediatric General, Thoracic, and Fetal Surgery, The Center for Fetal Research, Children’s Hospital of Philadelphia) J James M. Wilson (Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania) D Daniel Reker (Department of Biomedical Engineering, Duke University) D Drew Weissman M Michael J. Mitchell

Abstract

mRNA-based gene editing therapeutics offer the potential to permanently cure diseases but are hindered by suboptimal delivery platforms. Here, we devise a robust combinatorial chemistry for the plug-and-play assembly of structurally diverse biodegradable ionizable lipids from amines/thiols and dialkyl maleates. After screening 500 ionizable lipids, we obtained structure−activity relationships essential for effective in vitro mRNA delivery with the help of machine learning. Furthermore, we identified a lead ionizable lipid candidate that produced potent lipid nanoparticles for the delivery of various gene editing tools in wild-type and genetically modified mice compared to literature and industry benchmark lipid nanoparticles. Mechanistically, our lipid nanoparticles show favorable physicochemical properties, which could synergistically contribute to the superior delivery performance. This study highlights the utility of this synthetic method as well as the generality of this platform for potent in vivo gene editing.

Article Details

Volume / Issue Vol. 123, Issue 22
Published June 02, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (15)

X

Xuexiang Han

Y

Ying Xu

A

Adele S. Ricciardi

Department of Bioengineering

J

Junchao Xu

Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

Y

Yan Xiang

Department of Biomedical Engineering, Duke University

R

Rohan Palanki

V

Vivek Chowdhary

Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania

L

Lulu Xue

Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

N

Ningqiang Gong

Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

M

Mohamad-Gabriel Alameh

W

William H. Peranteau

Division of Pediatric General, Thoracic, and Fetal Surgery, The Center for Fetal Research, Children’s Hospital of Philadelphia

J

James M. Wilson

Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania

D

Daniel Reker

Department of Biomedical Engineering, Duke University

D

Drew Weissman

M

Michael J. Mitchell